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Abstract 
Traditionally, glycyrrhizic acid has been used to form polydentate 
complexes. For the first time in the presented paper, the complexa-
tion of the Plant’s Flavonoids (Quercetin (Qu) and its glycoside - Ru-
tin (Rut)) with the novel Russian antiviral drug Camphecene 
(Camph) was investigated. The complexes obtained at different mo-
lar ratios were studied using UV/Vis spectroscopy. Formation of the 
host: guest complexes were registered: Qu and Rut molecular com-
plexes (Camph+2Qu; Camph+2Rut) with a stability constant 
K = 3.3·108 M-2. Comparison of the binding constants of the obtained 
complexes shows that the efficiency of Camphecene complexation 
with the participation of flavonoids is more efficient than with the 
participation of triterpenoids. Besides, it was found that the com-
plexes of Camphecene with the quercetin and rutin are soluble in wa-
ter, in contrast to the complexes with triterpenoids, which makes it 
possible to increase the bioavailability of both Camphecene and fla-
vonoids. The obtained results demonstrate the high potential of fla-
vonoids Qu and Rut to the development of novel pharmaceutical 
forms using the example of Camphecene in the form of molecular 
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1. Introduction
It is known that a decrease in therapeutic doses of medici-
nal substances and prolongation of action is possible when 
they are clathrate with plant glycosides. This property was 
used in the approach of Academician G. A. Tolstikov to 
reduce therapeutic doses of drugs and prolong the action 
[1-3]. In this regard, the presented work considers the 
possibilities of synthesizing new supramolecular complex-
es of Qu and Rut using the new antiviral drug Camphecene 
for the development of low-dose pharmaceutical substanc-
es on their basis. The authors consider that these pharma-
ceutical substances can be used to suppress the multiplica-
tion of viruses in the early stages. It is known that Cam-
phecene 1 (Fig. 1), has a broad spectrum of antiviral activi-
ty. It is proved to be active against the influenza virus 
strains type A and type B [4]. 
The purpose of this work is to synthesize and study su-
pramolecular complexes based on the scaffold monoterpe-
noid Camphecene and plant flavonoids to develop, in the 
future, previously unknown low-dose pharmaceutical sub-
stances with antiviral activity. Influenza is known to be 
the most common and dangerous respiratory viral infec-
tion. It causes annual epidemics and pandemics, leading to 
significant increases in morbidity and mortality in all re-
gions of the world. In connection with the growing num-
ber of cases of viral infections and especially resistant 
viral strains, it is necessary to improve the available ther-
apeutic methods, complementing them with the discovery 
of new antiviral agents. On the other fist, it is widely rec-
ognized that the medical heritage of plants is a valuable 
resource for the treatment of infectious disorders. This 
indicates a growing interest in antiviral products based on 
secondary plant metabolites [5, 6]. 
One of the unique plant components used in traditional 
medicine is bioflavonoids quercetin and rutin (Fig. 1). 
Plant flavonoids 2 and 3 are attracting more and more 
attention of chemists and pharmacologists due to the wide 
spectrum of their biological activity. Flavonoids have long 
attracted scientific interest as antiviral agents - in a few  
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Fig. 1 Structures of a) Camphecene (1), C12H21NO; b) Quercetin 
(2), C15H10O7; c) Rutin (3), C27H30O16 
studies, they have shown an inhibitory effect on proteases 
of various types of coronaviruses [7]. 
Quercetin (Qu) is one of the most important plant mol-
ecules, showing pharmacological activity such as antiviral 
and anti-inflammatory effects. It has also been demon-
strated to have a wide range of anti-cancer properties, and 
several reports indicate its efficacy as a cancer‐preventing 
agent [8]. Quercetin 2 (Fig. 1), chemical name 
2‐(3,4‐dihydroxy phenyl)‐3,5,7‐trihydroxychromen‐4‐one 
or 3,3′,4′,5,7‐pentahydroxyflavone, is classified as a flavo-
nol, one of the six subcategories of flavonoid compounds, 
and is the major polyphenolic flavonoid found in various 
vegetables and fruits, such as berries, dill, apples, and 
onions [9]. 
According to research results [10], Qu and other sever-
al substances exhibited better potential inhibition than 
Hydroxy-Chloroquine against COVID-19 main protease 
active site and ACE2. Based on the results obtained by 
computational methods on molecular docking, it is antici-
pated that Qu could affect SARS‐CoV‐2 by interacting with 
3CLpro, PLpro, and/or S protein [8, 11]. 
Thus, Qu is currently promising as a biologically active 
substance of natural origin, capable of exerting a nonspe-
cific complex effect on inflammatory and destructive pro-
cesses in the body, and Qu be considered promising in the 
treatment of allergic pathology, inflammatory and non-
inflammatory diseases (Alzheimer's). One of the special 
effects of quercetin is its protective effect on the vascular 
endothelium, which is important in COVID-19 since endo-
thelial dysfunction inevitably develops in this pathology 
[7]. 
2. Experimental
The following reagents were used in this study: Quercetin 
(purity 98.2%) from DIA-M (Russia) and Rutin (99.4% 
purity) from Sichuan Xieli Pharmaceutical Co., Ltd. (Chi-
na), and locally produced chemicals of the chemically pure 
grade. 
Camphecene – 2-(E)-((1R,4R)-1,7,7-trimethylbicyclo 
[2.2.1] heptan-2-ylidene-aminoethanol was synthesized at 
the Novosibirsk Institute of Organic Chemistry (NIOCH SB 
RAS) (Fig. 2): а mixture of (1R)-(+)-camphor (1.0 equiv.), 
the appropriate amine (2.5 equiv.), and anhydrous ZnCl2 
(0.1% mol on camphor) was reflux for 5–12 h. Diethyl 
ether was added to the reaction mixture, after completion 
of the reaction. The organic layer was washed with brine, 
dried (Na2SO4), and evaporated. The crude product was 
subjected to vacuum distillation [12]. 
The complex of Camph and Qu and Rut was formed by 
mixing 96% alcohol solution. The process of complex for-
mation between Qu and Rut and Camph was analyzed us-
ing electron-optical UV-Vis spectroscopy (a SPEKS 
SSP 705-PC spectrometer (CJSC Spectroscopic Systems, 
Russia). 
The complexes of Qu/Rut and Camph were formed by 
mixing an alcohol solution of Qu/Rut and Camph at the 
molar ratio of 1:1 and 2:1 (using ethanol as alcohol). The 
stoichiometry of the complex was evaluated by the de-
pendence of optical density of a Camph solution (meas-
ured at 201 nm) on Qu/Rut concentration. A contribution 
of Qu/Rut to absorbance was corrected by subtracting the 
absorbance spectrum of Qu/Rut from the total absorbance 
spectrum. Measurements were carried out in a quartz cell. 
3. Results and Discussion
Following the objectives of the work, sets of complexes of 
bioflavonoids Qu and Rut with an antiviral drug Cam-
phecene at different molar ratios "guest: host" were syn-
thesized. 
For a detailed study of the processes of complexation 
of Qu and Camph, the absorption spectra of Camph in a 
mixture with different concentrations of Qu were investi-
gated. In the first step, complexes of Qu with Camph were 
obtained at molar ratios: 1:1 and 2:1 and studied by UV/Vis 
spectroscopy. The binding of Camph and Qu after mixing 
of their solutions was accompanied by changes in the  
(+)-Camphor 2-Aminoethanol Scaffold monoterpenoid–Camphecene 
Fig. 2 Scheme of obtaining the scaffold monoterpenoid – 
Camphecene [12] 
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absorbance spectrum of Camph indicating the complex 
formation of these compounds (Fig. 3). The UV-VIS spec-
trophotometric analysis of the mixture of Camph and Qu 
has shown that the increase in Qu concentration is accom-
panied by the change in the shape of the Camph spectrum 
due to complex formation (its maximum of absorbance 
becomes lower). As demonstrated in Fig. 3, with an in-
crease in the concentration of Qu from 0 to 0.125 mM, a 
bathochromic shift of the absorption maximum of Camph 
(201  215 nm) is recorded in the UV/Vis spectra, and a 
decrease in optical density is observed. 
Fig. 3 shows the Camph spectra, which are the differ-
ence absorption spectra of the mixture of Camph and Qu 
and the spectrum of Qu at a given concentration. 
An increase in the concentration of Qu (from 0.25 mM 
and higher) leads to the disappearance of the maximum 
absorption of Camph, which indicates the complete bind-
ing of Camph molecules in the presence of Qu (Fig. 4). 
Fig. 4 demonstrates from the dependence of the optical 
density on the concentration of Qu at the value of the max-
imum absorption band of Camph λmax1= 201 nm: the opti-
cal density sharply decreases its values depending on the 
concentration of Qu in the mixture. 
The study of Rut (Fig. 5) demonstrated similar changes 
in the UV/Vis spectra of the obtained complexes. When the  
Fig. 3 Absorption spectrum of Camphecene (CCamph = 0.5 mM) at 
different concentrations of Qu* (in 96% alcohol solution). The 
upper spectrum line corresponds to the absorbance spectrum of 
Camph in the absence of Qu (C= 0.0 mM). 
Fig. 4 Dependence of optical density on the concentration of 
quercetin 
Fig. 5 Absorption spectrum of Camphecene (CCamph = 0.5 mM)  
at different concentrations of Rut (*Rut 0.01 mM – standard solu-
tion of rutin) 
Rut concentration changes in the range from 0.05 to 
0.275 mM, a bathochromic shift of the absorption maxi-
mum of Camph is recorded (201  213 nm). 
In this study, the stability constants for the complex of 
Camph and Qu/Rut were analyzed by changes of optical 
density of Camph solutions (with its constant concentra-
tion, CCamph = 0.5 mM) with variable concentrations of 
Qu/Rut. To calculate the stability constant of the complex-
es, we used the Benesi-Hildebrand plot (1) [13]. Eq. (1) is 
applicable for certain experimental conditions (Camph 
concentration < Qu/Rut concentration). 
The stability constant of the nQu-Camph complex was 
estimated from the change in the optical density of Camph 
(λmax1 = 201 nm) at its fixed concentration in solutions in 
which the Qu (or Rut) concentration was varied. Eq. (1) 
allows, within the framework of one experiment, not only 
to estimate the stability constant of the complex (K) but 
also to determine the stoichiometry ratio "host: guest" (n) 
in the complex: 
∆𝐷 𝐷⁄ − 1 = 1 [Qu]𝑛⁄ ∙ 1 𝐾⁄  (1) 
where ∆𝐷 = ∆𝜀 ∙ [Camph] – change in the optical density of 
the solution, К – the constant of stability of the complex, 





The absorption spectrum of Camph was recorded at a 
wavelength of 201 nm, while the Camph concentration  
Fig. 6 Dependence of the slope of the straight line D/D on 
1/[Qu]2 
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was constant and amounted to 0.5 mM. The obtained de-
pendence of the absorption intensity of Camphecene 
(λ = 201 nm) on the concentration of Qu is shown in 
Fig. 6. 
From the slope of the straight line ∆𝐷 𝐷⁄  depending on 
1/[Qu]
2
 (Fig. 6), the stability constant of the complex was 
calculated using Eq. (1). The stability constant for the 
Camph+Qu complex is 1/K = 3 10-9 M2 or K = 3.3 108 M-2. 
Recognizing the value of the binding constant, the 
change in the Gibbs energy was calculated. Obtained from 
the binding constant, the change in Gibbs’s energy  
∆G = -47.8 kJ. Based on the obtained negative value, it can 
be concluded that the reaction proceeds spontaneously 
during the formation of Qu and Camph complexes. Simi-
larly, according to Eq. (1), the stability constant of the 
complex Camph+Rut was calculated, 1/K = 3 10-9 M2 or  
K = 3.3 108 M-2. Using the value of the binding constant, 
the change in Gibbs’s energy was calculated. The change in 
the Gibbs energy ∆G =-47.8 kJ, which allows us to con-
clude that the reaction proceeds spontaneously during the 
formation of a complex of Rut with Camph. 
Thus, the values of the binding constant Camph for Qu 
and Rut are comparable, and the same conclusion can be 
drawn about the change in the Gibbs energy ∆G = -47.8 kJ. 
Comparison of the binding constants of the obtained 
complexes shows that the efficiency of Camphecene’s 
complexation with the participation of flavonoids is more 
efficient (K = 3.3 108 M-2 for the Camph+2Qu; 
Camph+2Rut complexes) than with the participation of 
triterpenoids (K = 6.94 106 M-2 for Camph+2GA) [14]. Al-
so, it was found that the complexes of Camphecene with 
the quercetin and rutin are soluble in water, in contrast to 
the complexes with triterpenoids, which makes it possible 
to increase the bioavailability of both Camphecene and 
flavonoids. 
4. Conclusions 
For the first time, the complexation of the Plant’s Flavo-
noids (Quercetin (Qu) and its glycoside - Rutin (Rut)) with 
the novel Russian antiviral drug Camphecene (Camph) 
was investigated.  
The complexes obtained at different molar ratios "host: 
guest" - 1:1 and 2:1 were studied using UV/Vis spectrosco-
py. 
Formation of the "host: guest" complexes were regis-
tered: Qu and Rut molecular complexes (Camph+2Qu; 
Camph+2Rut) with a stability constant K = 3.3 108 M-2. 
The obtained results demonstrate the high potential of 
flavonoids Qu and Rut to the development of novel phar-
maceutical forms using the Camphecene in the form of 
molecular complexes, as the novel forms of delivery. 
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